EORTC – European Organisation for Research and Treatment of Cancer shared a post on LinkedIn:
“New advancements in breast cancer research!
Our latest publication explores the use of machine learning to characterise the tumour-immune microenvironment in the EORTC 10994/BIG 1-00 trial.
Discover how AI is helping us understand immune infiltrates and their prognostic implications.“
Machine learning-based spatial characterization of tumor-immune microenvironment in the EORTC 10994/BIG 1-00 early breast cancer trial.
Authors: Ioannis Zerdes, et al.
